R.I.C.-Calcio

Quick links

Choose a section

Quick links to important sections

Advertisements

R.I.C.-Calcio

Advertisements
Advertisements
Advertisements

Overview of R.I.C.-Calcio

R.I.C.-Calcio is a specific pharmaceutical agent used to address high potassium levels in the blood. It is a synthetic polymer that works locally within the gut to capture and remove excess potassium from the body.

Property Description
Active ingredient Calcium Polystyrene Sulfonate
Form Powder for oral or rectal suspension
Pharmacological class Cation-exchange resin, Antihyperkalemic agent
Common use Management of hyperkalemia (high blood potassium)
Origin Synthetic polymer

What Type of Medicine is R.I.C.-Calcio? (Identity and Classification)

R.I.C.-Calcio is classified as an antihyperkalemic agent, with its sole active component being Calcium Polystyrene Sulfonate. It belongs to the therapeutic group of cation-exchange resins, a synthetic class designed for non-systemic action. This class is recognized for its ability to selectively bind ions within the gastrointestinal tract. This compound is notably a synthetic polymer that remains non-absorbable, a key feature differentiating it from drugs that act systemically. The calcium form of the polystyrene sulfonate is often utilized in managing high potassium for patients who require strict monitoring of their sodium intake.


Composition and Physical Form of R.I.C.-Calcio (Chemistry and Preparation)

As a single-ingredient product, R.I.C.-Calcio features only Calcium Polystyrene Sulfonate. The substance is typically supplied as a powder for suspension, which necessitates mixing with an aqueous vehicle before administration. This physical form is essential because the active resin is a non-soluble, granular material. The product can be administered via the oral route or as a rectal suspension (enema). The chemical property of utilizing calcium ions in its exchange process is a primary differentiating factor, distinguishing it from the related Sodium Polystyrene Sulfonate (SPS), which uses sodium ions, a distinction that is medically significant.


What is the General Purpose of This Potassium Binder? (Core Benefit)

The general purpose of R.I.C.-Calcio is the management and safe reduction of elevated potassium levels in the blood, known as hyperkalemia. This condition is often observed in patients with chronic renal issues, where the body struggles to excrete potassium efficiently. By functioning as a targeted potassium binder, the medication uses the ion-exchange mechanism to capture excess potassium. The core medical benefit is the controlled removal of excess potassium from the body via the stool, providing an essential therapeutic pathway for managing this critical electrolyte imbalance.

Advertisements

What side effects are possible with R.I.C.-Calcio?

Possible Side Effects and Safety Information

The safety profile of calcium products like R.I.C.-Calcio is primarily defined by the risk of gastrointestinal disturbances and systemic calcium overload.

Adverse Reaction Categories

System-Organ Class Common Reactions Serious/Rare Reactions
Gastrointestinal Disorders Constipation, gas, bloating, stomach upset Severe nausea, vomiting
Metabolism & Nutrition — Hypercalcemia (high calcium in blood), Hypercalciuria (high calcium in urine)
Renal & Urinary Disorders Increased urination (with hypercalcemia) Calcium nephrolithiasis (kidney stones)
Immune System Disorders — Hypersensitivity reactions (allergic reactions)

Serious Adverse Reactions

High calcium levels (hypercalcemia) represent the most serious documented risk, particularly with high doses or prolonged use. Symptoms of hypercalcemia can include excessive thirst, frequent urination, confusion, muscle weakness, and, rarely, can affect heart rhythm or lead to kidney failure. Serious allergic reactions are rare but require immediate attention.

Safety Considerations and Restrictions

Safety documents emphasize that the risk of metabolic side effects, such as hypercalcemia and hypercalciuria, is dose-related and increases when the Tolerable Upper Intake Level (UL) is exceeded. Monitoring of calcium levels in blood and urine may be necessary during long-term therapy.

Restrictions for Use: The use of R.I.C.-Calcio is generally restricted or requires particular caution in patients with existing conditions that predispose to high calcium levels, such as sarcoidosis, certain malignancies, or hyperparathyroidism. Patients with pre-existing kidney dysfunction or a history of kidney stones also face a higher risk of adverse outcomes.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Calcium Polystyrene Sulfonate (R.I.C.-Calcio) overdose centers on severe electrolyte derangement and major gastrointestinal complications. Overdose may present with signs of significant hypokalaemia (low potassium), leading to symptoms like muscle weakness, confusion, hyporeflexia, and irritability. Potential hypercalcaemia or hypomagnesaemia are also documented clinical manifestations.

Severe outcomes officially listed include cardiac arrhythmia, the progression of hypokalaemia to paralysis and apnoea, and life-threatening complications such as intestinal obstruction, necrosis, and perforation. In the event of an overdose, patients must seek prompt medical advice immediately if new severe symptoms appear, including severe abdominal pain, stomach distension, or rectal bleeding.

Established management involves taking appropriate measures to correct documented serum electrolyte abnormalities and physically removing the administered resin from the alimentary tract. No specific antidote is mentioned in the official regulatory documentation. Particular care is noted for children and neonates, who have a specific documented risk of faecal impaction following rectal administration.

Advertisements

Therapeutic Uses of R.I.C.-Calcio

R.I.C.-Calcio is a therapeutic agent that is commonly applied in situations where the body's vital electrolyte balance may be compromised due to impaired kidney function. Its core use is for the management of hyperkalemia (elevated blood potassium levels), a condition that can arise from acute renal failure, chronic kidney disease (CKD), anuria, or severe oliguria. The agent is used for patients requiring supportive management of this physiological strain.

A key benefit is support in managing this underlying risk, helping to stabilize the internal environment and ease challenging symptoms. It is commonly used to help prevent the most severe complication of hyperkalemia: life-threatening disruptions to the heart's electrical rhythm, known as cardiac arrhythmias. By effectively lowering potassium, R.I.C.-Calcio assists with easing the physiological strain and supports the patient's overall physiological stability. This offers supportive symptomatic assistance for conservative CKD management, contributing to day-to-day comfort.

“This agent is relevant for easing symptoms linked to organ-specific functional stress in contexts involving heightened systemic burden.”

Quick Fact: Relief for Electrolyte Strain
Common Use Context: Maintenance therapy in chronic kidney disease and management during acute renal failure.
Primary Benefit: Supports the controlled reduction of serum potassium levels.
Advertisements

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use R.I.C.-Calcio

The eligibility profile for R.I.C.-Calcio (Calcium Polystyrene Sulfonate) is strictly defined by regulatory authorities and centers on patient safety and pre-existing health status. Use is established for adults and children requiring the management of hyperkalemia (high blood potassium).


Absolute Contraindications

The medicine must not be used by populations with certain metabolic and gastrointestinal conditions:

  • Patients with Hypokalemia (serum potassium concentration below 5 mmol/L).
  • Patients with Obstructive bowel disease or severely compromised gastrointestinal motility.
  • Patients with conditions associated with Hypercalcemia.
  • Patients with a history of hypersensitivity to polystyrene sulfonate resins.

Age-Specific and Reproductive Restrictions

Population Eligibility Status (Regulatory Wording)
Neonates Oral administration is contraindicated; rectal use is contraindicated if gut motility is reduced.
Infants Requires particular care, especially for premature or low birth weight infants.
Pregnancy Not recommended during pregnancy or for women of childbearing potential not using contraception.
Lactation A risk to the newborn cannot be excluded due to insufficient data.

Patients with renal impairment should be monitored closely, as they are identified as having risk factors for serious gastrointestinal events. If clinically significant constipation develops, the treatment must be discontinued.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define the interaction profile of R.I.C.-Calcio (Calcium Polystyrene Sulfonate) through physical binding interference and electrolyte-mediated effects. All interaction information is presented at a high, regulatory-aligned descriptive level.


Mandatory Restrictions and Strong Avoidance

Concomitant use with Sorbitol is restricted due to the documented risk of intestinal necrosis. Co-administration with magnesium- or aluminum-containing laxatives and antacids should also be avoided, as this carries a risk of systemic alkalosis and intestinal obstruction, particularly in patients with renal impairment. Additionally, the resin must not be mixed with high-potassium liquids, which reduces its binding effectiveness by competition.


Physical Binding and Timing Rules

As a non-absorbable cation-exchange resin, R.I.C.-Calcio may bind to other orally administered medications in the gastrointestinal tract, resulting in a decreased absorption and reduced exposure of the co-administered drug, including Thyroid Products and Lithium. To mitigate this risk, the regulatory profile mandates a separation of administration: other oral medicines must be taken at least 3 hours before or 3 hours after R.I.C.-Calcio.


Pharmacodynamic Cautions

The toxic effects of Digitalis-like drugs (cardiac glycosides) are officially noted as exaggerated if R.I.C.-Calcio induces secondary electrolyte imbalances, specifically hypokalaemia or hypercalcaemia.

Advertisements

Mechanism of Action

How R.I.C.-Calcio Works

Localized Cation Exchange and Potassium Sequestration

R.I.C.-Calcio (Calcium Polystyrene Sulfonate) functions as a non-absorbable synthetic polymer that acts exclusively within the gastrointestinal tract. Its core mechanism is cation exchange, where its bound calcium ions (Ca^2+) are swapped for excess potassium ions (K^+) present in the intestinal contents . This process sequesters the potassium, binding it chemically onto the resin structure; the resultant complex is non-absorbable.


Modulation of Systemic Electrolyte Redistribution

By continuously binding and removing potassium from the gut via fecal excretion, the drug creates a functional sink. This alters the concentration gradient, which in turn drives the passive movement of potassium from the circulating plasma into the intestinal lumen to maintain electrochemical balance. This net removal of potassium contributes to a decrease in the systemic plasma potassium concentration, which is the predictable physiological consequence of the drug's action.


⏳ Mechanistic Constraints of Physical Transport

The mechanism's efficiency is constrained by the need for the resin to physically travel through and dwell in the colon where K^+ concentrations are highest; severely slow gastrointestinal transit time can impair the binding process. Additionally, the polymer has a finite, stoichiometric binding capacity, meaning the amount of potassium it can remove per dose is inherently limited by the physical quantity of the drug administered.

Advertisements

Dosage and Administration Information

R.I.C.-Calcio (Calcium Polystyrene Sulfonate) is administered exclusively via the gastrointestinal tract, using either the oral or rectal route. It is supplied as a powder for suspension, requiring specific preparation before use.

Administration and Dosage Patterns

The powder must be suspended immediately prior to use, typically mixed with a small amount of water or syrup in a ratio of 3 to 4 mL of liquid per gram of resin. The resin is not mixed with fruit juices or squash, as these liquids may contain potassium.

Administration Route Standard Adult Regimen Frequency and Timing
Oral 15 grams per dose Administered three or four times a day.
Rectal (Enema) 30 grams of resin Given once daily as a retention enema.

Oral administration is typically used for maintenance, while the rectal route may be reserved for patients unable to tolerate the oral suspension. The rectal enema is retained for at least nine hours and followed by irrigation to ensure the resin's complete removal.

Usage Constraints

Proper use involves a required time separation from other oral medications. The resin is taken at least three hours before or three hours after any other oral medication to prevent the non-absorbable resin from binding to and inactivating the other drug.

For pediatric use, the dosage is based on body weight, starting with a typical acute dose of 1 gram per kg daily in divided doses. Oral administration is contraindicated in neonates.

Advertisements

Recent Clinical Evidence

Research Evidence Overview of Studies for R.I.C.-Calcio

R.I.C.-Calcio was evaluated in research exploring the management of high potassium levels, a condition known as hyperkalemia, which is often seen in individuals with impaired kidney function. The research provides context, but not individual predictions, describing group patterns, not personal outcomes.

Evidence for use in Managing High Blood Potassium (Hyperkalemia)

The research base includes different study types, such as controlled clinical studies and various observational studies. Available research has explored the use of this compound in adults, particularly those with Chronic Kidney Disease (CKD) and individuals experiencing Acute Renal Failure.

Researchers mainly focused on outcomes related to systemic or functional imbalance, specifically tracking shifts in serum potassium levels and the time interval over which different concentrations were observed in the studies. The evidence gathered so far contributes to the broader evidence landscape related to potassium concentrations in the observed populations.

Research on Preventing Cardiac Risks Related to High Potassium

Evidence related to the evaluation of heart rhythm patterns (cardiac arrhythmias) is available primarily through Retrospective Cohort Studies and Clinical Case Studies. Research so far describes patterns related to the use of R.I.C.-Calcio and the frequency of heart rhythm changes observed in some studies. However, the evidence is described as being indirect and certainty remains low due to the nature of the research.

What is Still Uncertain About R.I.C.-Calcio Studies (Evidence Gaps)

The evidence quality varies across studies, and sample sizes were modest in many older trials. A significant gap is the limited information for long-term outcomes when the compound is used for ongoing hyperkalemia management. Additionally, comparative evidence is lacking in large-scale studies that specifically compare R.I.C.-Calcio to newer potassium-binding agents. Therefore, the findings highlight what is still uncertain about the product’s use in various scenarios.

Key Studies & References

  1. Calcium Polystyrene Sulfonate (MedlinePlus Drug Information)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about R.I.C.-Calcio (FAQ)

Q: Can R.I.C.-Calcio cause stomach upset or nausea?

Official safety information indicates that R.I.C.-Calcio can cause common side effects that affect the digestive system, such as gas, bloating, stomach upset, and constipation. Severe nausea or vomiting is also reported. Official product information suggests contacting a healthcare professional for serious side effects.


Q: Is a headache a known side effect of R.I.C.-Calcio?

Headache is not typically listed as one of the common or isolated side effects in the regulatory documentation for this product. However, official information describes headache as a possible sign of hypercalcemia (high calcium levels), which is a dose-related risk associated with R.I.C.-Calcio that may require monitoring.


Q: Is it normal to feel a certain way when first starting R.I.C.-Calcio?

It is common to experience mild gastrointestinal issues, such as bloating, gas, and constipation, especially when starting R.I.C.-Calcio. The regulatory safety profile emphasizes that these are common adverse reactions. The prescribing information emphasizes that signs of more serious metabolic changes may require monitoring.


Q: Is R.I.C.-Calcio generally appropriate for older adults?

The regulatory documents do not provide specific data on how the medication affects older adults compared to younger populations. However, caution is advised for patients with existing risk factors, such as impaired kidney function, which may be more prevalent in geriatric populations, and closer medical monitoring may be appropriate.


Q: Can teenagers use R.I.C.-Calcio?

Official product information states that R.I.C.-Calcio is used in pediatric populations, including children and infants, with dosing based on weight and blood potassium levels. Regulatory documents contain the specific caution that oral administration is contraindicated for neonates.


Q: Does R.I.C.-Calcio interact with caffeine?

According to the official product information, a physical binding interaction can occur between the resin and other oral medications or products. To mitigate the risk of reduced effectiveness of the co-administered product, official labeling mandates a separation of at least three hours between R.I.C.-Calcio and any other oral product, including those containing caffeine.


Q: What is the long-term safety profiles associated with R.I.C.-Calcio?

The safety information discusses the risk of high calcium levels (hypercalcemia) in the context of long-term use and high doses. Official sources advise that ongoing monitoring of calcium levels is often necessary. Research reviews also indicate that information regarding very long-term safety outcomes beyond the typical study duration may be limited.


Q: Does R.I.C.-Calcio require a doctor's visit to get?

Yes, regulatory and medical documentation classifies R.I.C.-Calcio (Polystyrene Sulfonate resins) as a prescription-only medication for the management of high potassium levels (hyperkalemia).


Q: How long does it usually take to notice any effect from R.I.C.-Calcio?

Regulatory references indicate that the effect of R.I.C.-Calcio on potassium levels is generally delayed. Measurable changes in serum potassium levels are typically observed several hours to a day after the product is administered, meaning it is not used for emergency situations.


Q: What happens if I forget to use R.I.C.-Calcio for a day?

Official patient guidance for R.I.C.-Calcio recommends taking a missed dose as soon as it is remembered. However, if the time is close to the next scheduled dose, regulatory guidance states to skip the missed dose and resume the normal schedule. Regulatory guidance states that doubling the next dose is not recommended.


Q: Is R.I.C.-Calcio supposed to be used long-term?

R.I.C.-Calcio is used to manage high potassium, which can be a chronic condition, especially for those with long-term kidney issues. Therefore, the medication may be prescribed for ongoing, long-term use. The official duration of therapy described depends on the individual's needs and the severity of the hyperkalemia.


Q: Who can or cannot use R.I.C.-Calcio?

According to official regulatory documents, R.I.C.-Calcio is indicated for adults and children who require management of hyperkalemia (high blood potassium). The product is contraindicated, meaning it should not be used, in patients who have low potassium levels, obstructive bowel disease, or a known hypersensitivity to polystyrene sulfonate resins.


Q: What does it mean if R.I.C.-Calcio is generally well-tolerated?

This regulatory phrasing means that in clinical studies, the frequency of serious adverse effects was low. The most commonly reported side effects were related to the digestive system, such as gas and bloating, and these symptoms often lessened over time, suggesting the product is generally acceptable to users.


Q: Can R.I.C.-Calcio be split or crushed before use?

R.I.C.-Calcio is supplied as a powder that must be mixed with liquid to form a suspension immediately before use. Official administration instructions emphasize specific preparation with liquid, and details regarding splitting or crushing are not provided in the product labeling.


Q: Is R.I.C.-Calcio described as acting quickly or slowly?

R.I.C.-Calcio is officially described as having a slow onset of action. The regulatory label clarifies that it is not intended for use in life-threatening, emergency hyperkalemia where an immediate reduction of potassium levels is necessary.


Q: Is there a specific time of day R.I.C.-Calcio is typically used?

The official product information does not specify a required time of day for use, such as morning or evening. The key instruction is related to frequency (typically one to four times daily) and the mandatory separation of at least three hours from any other oral medication.


Q: Is R.I.C.-Calcio approved in countries outside the US?

Yes, the active ingredient, Calcium Polystyrene Sulfonate, is a widely recognized medication. It has received regulatory authorization in numerous international jurisdictions, including countries within the European Union (EMA), the United Kingdom (MHRA), and others.


Q: Are there any warnings about driving or operating machinery while using R.I.C.-Calcio?

Official regulatory warnings do not specifically prohibit driving. However, because the product can cause changes in blood chemistry, such as low blood pressure or severe fluid imbalance, side effects like dizziness or fainting are possible, and regulatory information indicates that awareness of these potential risks may be appropriate.


Q: Is the purpose of R.I.C.-Calcio different for men versus women?

No. The regulatory indication for R.I.C.-Calcio is the management of hyperkalemia (high blood potassium) in the body. This therapeutic purpose is consistent for all adult populations, regardless of gender.


Q: What is the relationship between R.I.C.-Calcio and other mineral deficiencies?

R.I.C.-Calcio functions as a cation-exchange resin, meaning it swaps its own ions for others in the gut. The official warnings and precautions section notes that it may lead to the removal of other positive ions. Regulatory documents indicate that monitoring for low levels of magnesium (hypomagnesemia) and other minerals may be necessary during treatment.

Advertisements

How should R.I.C.-Calcio be stored and disposed of?

Official Storage and Disposal Requirements

Storage and disposal instructions for R.I.C.-Calcio (Calcium Polystyrene Sulfonate) are defined by regulatory documents to ensure product stability and safety.

Storage Feature Official Requirement
Unopened Product Does not require any special storage conditions.
Opened Multi-dose Container Store at or below 25 C and keep tightly closed.
In-Use Stability The multi-dose container must be discarded 1 month (30 days) after first opening.
Prepared Suspension Must be prepared immediately before use (used freshly) and not stored.
Child Safety Keep this medicine out of the sight and reach of children.

Any unused or expired product and waste material must be disposed of in accordance with local regulatory requirements.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of R.I.C.-Calcio found in:

A-Z Index: